Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations
SAN DIEGO , July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026.
Barchart Research What to Expect from ILMN Earnings ILMN Generated July 29, 2026 Current Price $194.82 EPS Estimate $$1.23 Consensus Rating Moderate Buy Average Move 8.69% Illumina Reports Tomorrow With...
Illumina Earnings: What To Look For From ILMN
3 Healthcare Stocks with Questionable Fundamentals
3 Profitable Stocks We Find Risky
Partners will use unprecedented data scale to advance more precise medicines to approval
SAN DIEGO , July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026....
New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology
2 Mooning Stocks Worth Investigating and 1 We Avoid